{"url_path":"/sec/cik-0001440153/10-k/2026/item-10","section_key":"item-10","section_title":"Item 10 ****DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE**","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-07-20","source_url":"https://www.sec.gov/Archives/edgar/data/1440153/0001096906-26-001097-index.html","accession_number":"0001096906-26-001097","cik":"0001440153","ticker":null,"issuer_name":"Bakhu Holdings, Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1440153/0001096906-26-001097-index.html","primary_entity_key":"0001440153","primary_entity_name":"Bakhu Holdings, Corp."},"word_count":1046,"has_tables":true,"body_markdown":"**ITEM 10.****DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE** \n\n \n\n**Directors and Executive Officers**\n\n \n\nBetween January 24, 2025 and January 28, 2025, following the deadlock and inability of the then board to agree on the terms of the Employment Agreement for then CEO Teddy Scott and Consulting Agreement of Mitch Kahn, all the then officers and directors, Teddy Scott, Mitch Kahn, Aristotle Popolizio, Peter Whitton, Alvin Sun and Juan Carlos Garcia La Sienra, resigned.\n\n \n\nOn March 18, 2026 Konstantia (Nadia) Galazi was appointed as the sole director, the President, CEO, Secretary and CFO of the Company.  \n\n \n\nOn April 10, 2026, Karl E. Watkin, was appointed as a director of the Company.  \n\n \n\nOur current directors and executive officers are as follows:\n\n \n\n**Name**\n\n \n\n**Age**\n\n \n\n**Title**\n\n**Director Since**\n\nKonstantia (Nadia) Galazi\n\n \n\n53\n\n \n\nPresident, CEO, Secretary, CFO and Director\n\nMarch 2026\n\n \n\n \n\n \n\n \n\n \n\n \n\nKarl E. Watkin\n\n \n\n70\n\n \n\nDirector\n\nApril 2026\n\n \n\n**Term of Office**\n\n \n\nAll our directors hold office until the next annual general meeting of the stockholders or until their successors are elected and qualified. The officers are appointed by, and serve at the pleasure of, our board of directors.\n\n \n\n**Family Relationships**\n\n \n\nThere are no family relationships between any of our directors or executive officers, either by blood or by marriage.\n\n \n\n**Background and Business Experience**\n\n \n\nThe business experience during the past five years of each of the persons serving as an officer of director is described below.\n\n \n\n**Konstantia (Nadia) Galazi**has extensive experience in accountancy, corporate governance, anti-money laundering and regulatory compliance, with over two decades of professional experience in regulated environments, including FCA-regulated firms and AIM-listed group structures and their subsidiaries. She has served as a company secretary across various public limited companies and has held Finance Director roles within a number of UK companies, with responsibility for financial management, governance frameworks and statutory compliance. Her experience includes involvement in complex corporate transactions, including share-for-share exchanges, group restructurings and governance implementation across multi-jurisdictional entities. She previously served as a director of Newgate Solutions Ltd, a subsidiary of NextGate Solutions, Inc. (Pasadena, California), a healthcare technology company specializing in identity resolution and Enterprise Master Person Index (EMPI) solutions. NextGate Solutions, Inc. was acquired by Rhapsody, a global healthcare data interoperability company backed by Hg Capital, in March 2022 and subsequently integrated into its platform. In addition, she served as Compliance Officer and Deputy AML Manager at AGK Partners, Chartered Accountants, London, for over 20 years, with responsibility for anti-money laundering frameworks, regulatory compliance and governance oversight, including matters relating to proceeds of crime regulations. Ms. Galazi brings significant experience in financial oversight, regulatory remediation and governance implementation, and is well positioned to support companies in achieving and maintaining compliance and good standing within applicable regulatory and reporting frameworks.\n\nPage **56**\n\n**Karl E. Watkin** is the owner and controls Menelaus Holding FZ LLC and PhytoCyte Pty Ltd. Mr. Watkin is an entrepreneur, director, salesman, strategist and inspirational leader with a proven track record of identifying and developing emerging technologies. Raised $1bn+ in investment funds; Mr. Watkin has been a climate change activist for 30 years. He Chaired the United Nations Foundation Bio Energy Board for 5 years. He was a United Nations Delegate at New York, Copenhagen and Bali COPs. Mr. Watkin has chaired and delivered the white papers on Climate Change Mitigation and Adaptation for the UNF, implemented worldwide. Mr. Watkin is currently leading the development of a number of Pharmaceutical and bio science technologies and products in UK, Australia, New York, Hong Kong and Vietnam. He has significant public company corporate governance experience and specialized in developing start-up businesses for the last 40 years, successfully bringing those businesses from concept to IPO.\n\n \n\n**Directorships**\n\n \n\nNo director or person nominated or chosen to become a director holds any other directorship in any company with a class of securities registered pursuant to Section 12 of the Exchange Act, or subject to the requirements of Section 15(d) of the Exchange Act or any other company registered as an investment company under the Investment Company Act of 1940.\n\n \n\n**Section 16(a) Beneficial Ownership Reporting Compliance**\n\n \n\nSection 16(a) of the Exchange Act requires our directors, executive officers, and persons that own more than 10% of a registered class of our equity securities to file with the SEC initial reports of ownership and reports of changes in ownership of our equity securities. Officers, directors, and greater than 10% stockholders are required to furnish us with copies of all Section 16(a) forms they file.\n\n \n\nBased solely on its review of the copies of such forms filed with the SEC electronically, received by us and representations from certain reporting persons, for the fiscal year ended July 31, 2024, the officers and directors, and certain beneficial owners of more than 10% of equity have all failed to file the required beneficial ownership reports. We have requested that such parties file the delinquent reports to comply with their filing requirements.\n\n \n\n**Code of Ethics**\n\n \n\nOn September 22, 2020, we adopted a Code of Ethics that applies to our principal executive officer, principal financial officer, and principal accounting officer that is reasonably designed to deter wrongdoing and to promote:\n\n \n\n·honest and ethical conduct, including ethical handling of actual or apparent conflicts of interest between personal and professional relationships; \n\n \n\n·full, fair, accurate, timely, and understandable disclosure in SEC reports and in other public communications; \n\n \n\n·compliance with applicable governmental laws, rules, and regulations; \n\n \n\n·prompt internal reporting of violations of the Code of Ethics to the appropriate person or persons identified in the Code of Ethics; and \n\n \n\n·accountability for adherence to the Code of Ethics. \n\n \n\nThe description of the Code of Ethics contained in this Annual Report is qualified in its entirety by reference to the full text of the Code of Ethics, which is incorporated by reference to the full text of the charter filed as Exhibit 14.01 to our Current Report on Form 8-K filed October 1, 2020.\n\n \n\n**Committees of the Board**\n\n \n\nIn the absence of any applicable regulatory or trading exchange requirement, we currently do not have nominating, compensation, or audit committees or committees performing similar functions, and we do not have written nominating, compensation, or audit committee charters. Our board of directors believes that it is not necessary to have these committees at this time, because the directors can adequately perform the functions of such committees.\n\nPage **57**"}